Sciele Pharma, Inc. (NASDAQ:SCRX) today announced that the U.S. Food & Drug Administration (FDA)
Related Posts
Performance Health announces new TheraBand Kinesiology Tape- Chiropractic Economics, Hill Therapeutics partner for first Facebook Giveaway
- Michael Smith named ACA Sports Council National Student Liaison
- Helping Hands Gifts for Growth Grants awarded at the AMC
- Pioneering exercise program receives registered trademark from U.S. Government
